Antimicrobial Agents and Chemotherapy · 2020 · 37 citations · 15 references
PharmacyPharmacokineticsPharmacologyPharmacogeneticsPharmacokinetic VariabilityPopulation PharmacokineticsDrug DispositionInterindividual VariabilityPopulation Pharmacokinetic ModelingPulmonary PharmacokineticsTuberculosis PharmacotherapyActive Pulmonary TuberculosisEliminationElimination MechanismsN-acetyltransferase 2 PolymorphismPharmacogenomics Of Tuberculosis TreatmentPopulation Pharmacokinetic EliminationPopulation Pharmacokinetic InterpretationPopulation Pharmacokinetic Variation
; ≥10.52 μg·h/ml), and the 2-h INH serum concentrations (≥2.19 μg/ml), was associated with the strongest early bactericidal activity. The optimal dosages targeting the different indicators varied from 700 to 900 mg/day, 500 to 600 mg/day, and 300 mg/day for the rapid, intermediate, and slow acetylators, respectively. Furthermore, a PPK model for isoniazid among Chinese tuberculosis patients was established for the first time and suggested doses of approximately 800 mg/day, 500 mg/day, and 300 mg/day for fast, intermediate, and slow acetylators, respectively, after a trade-off between efficacy and the occurrence of side effects.
15
Global tuberculosis report (2014)
L.A. Gabbasova, E.R. Experts Who · 2014 · 13.2K citations
Junichi Azuma, Masako Ohno, Ryuji Kubota et al. · European Journal of Clinical Pharmacology · 2012 · 273 citations · Full text